Mustang Bio, Inc. - stock earnings
MBIO Quarterly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2023Q4 | -8.6 million USD | ? USD |
| 2023Q3 | -10.1 million USD | ? USD |
| 2023Q2 | -16.2 million USD | ? USD |
| 2023Q1 | -18.2 million USD | ? USD |
| 2022Q4 | -20.9 million USD | ? USD |
| 2022Q3 | -19.1 million USD | ? USD |
| 2022Q2 | -20.0 million USD | ? USD |
| 2022Q1 | -20.0 million USD | ? USD |
| 2021Q4 | -20.0 million USD | ? USD |
| 2021Q3 | -17.0 million USD | ? USD |
| 2021Q2 | -14.4 million USD | ? USD |
| 2021Q1 | -15.0 million USD | ? USD |
| 2020Q4 | -20.6 million USD | ? USD |
| 2020Q3 | -13.0 million USD | ? USD |
| 2020Q2 | -14.6 million USD | ? USD |
| 2020Q1 | -11.9 million USD | ? USD |
| 2019Q4 | -16.2 million USD | ? USD |
| 2019Q3 | -10.2 million USD | ? USD |
| 2019Q2 | -10.4 million USD | ? USD |
| 2019Q1 | -9.6 million USD | -50000 USD |
| 2018Q4 | -11.8 million USD | -50000 USD |
| 2018Q3 | -7.5 million USD | ? USD |
| 2018Q2 | -5.1 million USD | 50000 USD |
| 2018Q1 | -6.3 million USD | 50000 USD |
| 2017Q4 | -15.6 million USD | ? USD |
| 2017Q3 | -6.9 million USD | ? USD |
| 2017Q2 | -5.5 million USD | ? USD |
| 2017Q1 | -3.2 million USD | ? USD |
| 2016Q4 | -8.7 million USD | ? USD |
| 2016Q3 | -1.9 million USD | ? USD |
| 2016Q2 | -1.1 million USD | ? USD |
| 2016Q1 | -903000 USD | ? USD |
| 2015Q4 | -911000 USD | ? USD |
| 2015Q3 | -716000 USD | ? USD |
MBIO Yearly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2023 | -51.6 million USD | ? USD |
| 2022 | -78.9 million USD | ? USD |
| 2021 | -64.1 million USD | ? USD |
| 2020 | -62.1 million USD | ? USD |
| 2019 | -48.2 million USD | ? USD |
| 2018 | -30.7 million USD | ? USD |
| 2017 | -31.3 million USD | ? USD |
| 2016 | -12.7 million USD | ? USD |
| 2015 | -5.4 million USD | ? USD |
MBIO
Price: $0.32
52 week price:
Earnings Per Share: -6.00 USD
P/E Ratio: -0.15
Exchange: NCM
Sector: Healthcare
Industry: Biotechnology
Volume: 169948
Ebitda: -6.9 millionMarket Capitalization: 5.3 million